Back

Machine Learning-Guided Engineering of High-Affinity Cross-Reactive Antibodies with Minimal Mutations

Hugo, D.; Grindel, A.-L.; Thenier, F.; Pluchart, C.; Munch, M.; Oliveira, C.; Dubois, S.; Le Drezen, C.; Guerois, R.; Maillere, B.; Truillet, C.; Nozach, H.

2026-07-16 molecular biology
10.64898/2026.07.15.738714 bioRxiv
Show abstract

Antibodies raised against human targets often fail to recognize their animal orthologs, limiting preclinical evaluation in relevant models. We developed a Deep Mutational Scanning (DMS)-coupled deep learning strategy to engineer potent cross-reactive antibodies with minimal sequence divergence. Starting from C4, a fully human anti-PD-L1 antibody with weak recognition of murine PD-L1, DMS identified substitutions that improved binding to both human and mouse antigens. Conventional recombination of beneficial mutations generated highly cross-reactive antibodies but required 13 to 15 substitutions. To reduce this mutational burden, a deep learning model trained on DMS-derived sequence-binding data was used to identify minimal mutation combinations predicted to retain high affinity. This approach yielded variants carrying only 4 to 5 substitutions, with in vitro and cellular binding properties comparable to highly mutated antibodies. Epitope mapping, structural modeling and in vivo assessment further confirmed that these engineered antibodies retained PD-1/PD-L1 blockade and demonstrated therapeutic activity in a mouse tumor model.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.